Author:
Cao Xin,Ye Qing,Orlowski Robert Z.,Wang Xiaoxiao,Loghavi Sanam,Tu Meifeng,Thomas Sheeba K.,Shan Jatin,Li Shaoying,Qazilbash Muzaffar,Yin C. Cameron,Weber Donna,Miranda Roberto N.,Xu-Monette Zijun Y.,Medeiros L. Jeffrey,Young Ken H.
Funder
National Cancer Institute and the National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Biology,Hematology
Reference26 articles.
1. Kristinsson SY, Eloranta S, Dickman PW, Andersson TM, Turesson I, Landgren O, et al. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Am J Hematol. 2013;88(1):60–5.
2. Swerdlow SH. International Agency for Research on Cancer, and World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues, World Health Organization classification of tumours. 4th ed. International Agency for Research on Cancer: Lyon, France; 2008.
3. Sekhar J, Sanfilippo K, Zhang Q, Trinkaus K, Vij R, Morgensztern D. Waldenström macroglobulinemia: a surveillance, epidemiology, and end results database review from 1988 to 2005. Leuk Lymphoma. 2012;53(8):1625–6.
4. Gertz MA. Waldenström macroglobulinemia: a review of therapy. Am J Hematol. 2005;79(2):147–57.
5. Gertz MA. Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management. Am J Hematol. 2013;88(8):703–11.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献